| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7edc2841170dcdc290b9c6a21bf986f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5365 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 |
| filingDate |
2017-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ae23956fa74923db501838281a72101
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cba686b428dc5fbddf4e91cb8f92e7a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb6052ed752f6a309ccff7710a9b4e25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_159cd0ff52baca19e8fb92da2eae6478 |
| publicationDate |
2017-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-106692159-A |
| titleOfInvention |
Application of dolutegravir in preparation of drugs for preventing or treating ischemic cardiovascular diseases |
| abstract |
The invention relates to new use of medicines and particularly relates to application of dolutegravir in prevention or treatment of coronary heart diseases, angina, myocardial ischemia and heart failure. In the application, the dosage range is 25mg to 500mg. |
| priorityDate |
2017-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |